GuidelineClinical and molecular hepatology2018
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.
Guideline in Clinical and molecular hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis.Gut and liver · 2021Trial
- AI-assisted ascites volumetry for prognostic stratification in HCC treated with Atezolizumab/Bevacizumab.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- Nutritional Risk Assessed by Royal Free Hospital-Nutritional Prioritizing Tool Predicts Survival in Cirrhosis With or Without Hepatocellular Carcinoma.Journal of Korean medical science · 2026Article
- Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease.Clinical and molecular hepatology · 2025Article
- Family resilience and demoralization in decompensated cirrhosis: parallel mediation of psychological resilience and social support.Frontiers in psychology · 2025Article
- [Pulmonary Complications in Patients with Liver Cirrhosis].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023Review
- Evidence-based hyponatremia management in liver disease.Clinical and molecular hepatology · 2023Review
- Clinical Characteristics and Early Diagnosis of Spontaneous Fungal Peritonitis/Fungiascites in Hospitalized Cirrhotic Patients with Ascites: A Case-Control Study.Journal of clinical medicine · 2023Article
- Initial treatment response and short-term mortality of spontaneous bacterial peritonitis in cirrhotic patients with hepatocellular carcinoma.Scientific reports · 2023Article
- Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis.Clinical and molecular hepatology · 2022Article
- Psoas muscle index predicts time to rehospitalization in liver cirrhosis: An observational study.Medicine · 2022Observational
- The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls.Clinical and molecular hepatology · 2022Review
- A non-invasive test that enables longitudinal monitoring of chronic liver disease: VCTE versus 2D-SWE.The Korean journal of internal medicine · 2022Article
- Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure.BMC infectious diseases · 2022Article
- Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.Digestive diseases and sciences · 2021Article
- Clinical impact of the treatment modality on small, solitary, recurrent intrahepatic hepatocellular carcinomas after primary liver resection.Annals of surgical treatment and research · 2021Article
- Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol.Journal of Korean medical science · 2021Article
- Impact of acute kidney injury on survival in patients with chronic hepatitis C: a retrospective cohort study.BMC infectious diseases · 2021Article
- Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study.Cancers · 2020Article
- Ascites management by cell-free concentrated ascites reinfusion therapy during recovery from drug-induced acute liver injury: a case report.Journal of medical case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.